Ascendia Pharmaceutical Solutions will participate in CPhI Americas 2026, taking place June 2–4, 2026, at the Pennsylvania Convention Center in Philadelphia. The event brings together pharmaceutical and biotech leaders focused on drug development, manufacturing, and supply chain execution across the Americas.
Click here to book your meeting with the team in advance of CPhI Americas 2026!
Ascendia Pharmaceutical Solutions will host meetings at exhibitor stand 1208. Attendees will have direct access to senior leadership, including Jim Huang, Ph.D., Chief Executive Officer; Bob Bloder, Chief Business Officer; Dr. Shaukat Ali, Senior Director of Scientific Affairs; Jared Hahn, Senior Director of Business Development; and Julie Hilton, Senior Director of Business Development.
These representatives will engage in focused discussions aligned with sponsor objectives. Conversations will address development strategy, complex formulation challenges, and manufacturing planning across clinical and commercial stages. The presence of executive leadership enables efficient, decision-driven interactions without delays in communication or follow-up.
Ascendia Pharmaceutical Solutions specializes in enabling drug programs that require advanced formulation and scalable manufacturing approaches. The company supports oral, topical, and sterile dosage forms, with emphasis on poorly soluble compounds, modified release technologies, and bioavailability enhancement.
At CPhI Americas 2026, the team will outline how integrated capabilities streamline development timelines and reduce technical risk. Discussions will focus on aligning formulation strategies with clinical goals, ensuring manufacturability, and preparing programs for commercial readiness.
Meetings at booth 1208 will center on practical problem-solving. Sponsors can expect direct input on formulation feasibility, process development considerations, and regulatory alignment. The goal is to provide clear direction that supports program advancement without unnecessary complexity.
Ascendia Pharmaceutical Solutions emphasizes transparency in development planning and execution. Engagements during the conference will reflect this approach, with clear communication on timelines, technical options, and scalability.
CPhI Americas 2026 offers a defined opportunity to engage with Ascendia Pharmaceutical Solutions in person. Meeting availability is limited due to high demand for executive-level discussions.
Sponsors and partners are encouraged to secure dedicated time at booth 1208 in advance. Contact Ascendia Pharmaceutical Solutions to schedule a meeting and initiate focused discussions on development, formulation, and manufacturing strategy.